You have 9 free searches left this month | for more free features.

JAK2 V617F mutation burden

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Carotid Plaque Burden in Philadelphia Negative

Recruiting
  • Myeloproliferative Neoplasm
    • Sohag, Egypt
      Faculty of Medicine
    Aug 14, 2023

    Arterial Function and Atherosclerosis in Essential

    Completed
    • Atherosclerosis
    • imaging
    • (no location specified)
    Oct 6, 2021

    Polycythemia Vera Trial (Givinostat Hydrochloride, Hydroxy Urea)

    Not yet recruiting
    • Polycythemia Vera
    • Givinostat Hydrochloride
    • Hydroxy Urea
    • (no location specified)
    Oct 19, 2023

    Patients With ET Treated With XAGRID®

    Completed
    • Essential Thrombocythemia (ET)
    • Anagrelide hydrochloride
    • Bari, Italy
    • +9 more
    Jul 6, 2021

    Polycythemia Vera Trial in Oklahoma City (Erlotinib)

    Terminated
    • Polycythemia Vera
    • Oklahoma City, Oklahoma
      University of Oklahoma Health Sciences Center
    Aug 7, 2020

    Anticoagulation in Gastroesophageal Varices and JAK2 Mutation

    Not yet recruiting
    • Gastroesophageal Varices
    • +2 more
    • Anticoagulation Agents
    • (no location specified)
    Aug 25, 2020

    Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Seattle

    Not yet recruiting
    • Castration-Resistant Prostate Carcinoma
    • +2 more
    • Biopsy
    • +9 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Nov 17, 2023

    Thrombotic Complications (CLOJAK)

    Not yet recruiting
    • Myeloproliferative Neoplasm
    • Blood sampling
    • Angers, France
    • +10 more
    Apr 20, 2023

    Myeloproliferative Tumor, Splanchnic Vein Thrombosis, JAK2 V617 Trial in London (Drugs, procedures)

    Enrolling by invitation
    • Myeloproliferative Neoplasm
    • +2 more
    • Drugs, procedures
    • London, United Kingdom
      Royal Free London Hospital
    Jul 29, 2021

    Monocytes Sub-populations in Thrombosis Associated With

    Recruiting
    • Myeloproliferative Neoplasm
    • 1 additional tube of blood
    • Bordeaux, France
    • +4 more
    Nov 30, 2022

    Myeloproliferative Diseases Trial in Bergamo, Pavia (ITF2357)

    Completed
    • Myeloproliferative Diseases
    • Bergamo, Italy
    • +1 more
    Dec 2, 2019

    Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in

    Not yet recruiting
    • Castration-Resistant Prostate Carcinoma
    • +2 more
    • Abiraterone Acetate/Niraparib
    • +5 more
    • Scottsdale, Arizona
      Mayo Clinic in Arizona
    Jan 9, 2023

    Myeloproliferative Tumors Trial in Canada, Spain, United States (VAC85135, Ipilimumab)

    Recruiting
    • Myeloproliferative Neoplasms
    • Birmingham, Alabama
    • +16 more
    Jan 27, 2023

    Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)

    Recruiting
    • Polycythemia Vera
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    May 19, 2023

    Chronic Myeloproliferative Tumors Trial in Germany, Italy, United Kingdom (givinostat)

    Active, not recruiting
    • Chronic Myeloproliferative Neoplasms
    • Berlin, Germany
    • +14 more
    Jun 14, 2021

    Hematocrit to Hemoglobin Ratio and Red Blood Cell Distribution

    Recruiting
    • Polycythemia Vera
      • Sohag, Egypt
        Faculty of Medicine
      Aug 12, 2023

      Portal Vein Thrombosis and Budd-Chiari Syndrome

      Recruiting
      • Hepatic Vein Thromboses
      • +9 more
      • Rotational thromboelastometry
      • +2 more
      • Chandigarh, Choose Any State/Province, India
        Postgraduate Institute of Medical Education and Research
      Nov 5, 2021

      Action of Interferon in Treatment of Myeloproliferative

      Recruiting
      • Myeloproliferative Neoplasm
        • Villejuif, Ile De France, France
          Inserm U1287
        Apr 28, 2023

        Polycythemia Vera Trial in Italy (AOP2014, Phlebotomies, ASA)

        Active, not recruiting
        • Polycythemia Vera
        • San Giovanni Rotondo, (FG) Puglia, Italy
        • +22 more
        Jan 10, 2023

        Myelofibrosis Trial in Paris (Ruxolotinib)

        Completed
        • Myelofibrosis
        • Paris, France
          ROBIN
        Jul 26, 2022

        Myelofibrosis Transformation in Essential Thrombocythemia, Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary

        Recruiting
        • Myelofibrosis Transformation in Essential Thrombocythemia
        • +2 more
        • Elotuzumab
        • Questionnaire Administration
        • Houston, Texas
          M D Anderson Cancer Center
        Feb 17, 2021

        Cystic Fibrosis Trial in Worldwide (ELX/TEZ/IVA, IVA, Placebo (matched to ELX/TEZ/IVA))

        Recruiting
        • Cystic Fibrosis
        • Innsbruck, Austria
        • +89 more
        Dec 20, 2022

        Myeloproliferative Neoplasia With Normal CBC and Thrombotic

        Recruiting
        • Thrombotic Patients
        • +2 more
          • Nantes, Loire-Atlantique, France
            Nantes University Hospital
          Sep 8, 2021

          Chronic GVHD Trial in Hanzhou (TQ05105 Tablet)

          Unknown status
          • Chronic Graft Versus Host Disease
          • TQ05105 Tablet
          • Hanzhou, Zhejiang, China
            The First Affiliated Hospital, Zhejiang University School of Med
          Jun 26, 2021